Innovative New Treatment Halts Progression in Hard-to-Treat Cancer
Photo: Brecht Corbeel / Unsplash
An experimental drug is showing great promise against mesothelioma by disabling the antioxidant defense system that the aggressive tumor cells rely on to survive. In an early clinical trial, this targeted approach successfully controlled disease progression in 67% of patients, offering new hope for treating asbestos-linked cancer and potentially other tumor types.
An experimental drug is showing great promise against mesothelioma by disabling the antioxidant defense system that the aggressive tumor cells rely on to survive. In an early clinical trial, this targeted approach successfully controlled disease progression in 67% of patients, offering new hope for treating asbestos-linked cancer and potentially other tumor types.